482 related articles for article (PubMed ID: 25572913)
21. Disparate survival and risk of secondary non-Hodgkin lymphoma in histologic subtypes of Hodgkin lymphoma: a population-based study.
Ali S; Olszewski AJ
Leuk Lymphoma; 2014 Jul; 55(7):1570-7. PubMed ID: 24067135
[TBL] [Abstract][Full Text] [Related]
22. Using primary site as a predictor of survival in mantle cell lymphoma.
Ambinder AJ; Shenoy PJ; Nastoupil LJ; Flowers CR
Cancer; 2013 Apr; 119(8):1570-7. PubMed ID: 23341329
[TBL] [Abstract][Full Text] [Related]
23. Breast cancer risk in female survivors of Hodgkin's lymphoma: lower risk after smaller radiation volumes.
De Bruin ML; Sparidans J; van't Veer MB; Noordijk EM; Louwman MW; Zijlstra JM; van den Berg H; Russell NS; Broeks A; Baaijens MH; Aleman BM; van Leeuwen FE
J Clin Oncol; 2009 Sep; 27(26):4239-46. PubMed ID: 19667275
[TBL] [Abstract][Full Text] [Related]
24. Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis.
Rusthoven K; Chen C; Raben D; Kavanagh B
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):192-8. PubMed ID: 18078720
[TBL] [Abstract][Full Text] [Related]
25. Analysis of chemotherapy effect on the second primary malignancy for head and neck cancer patients by a nomogram based on SEER database.
Li X; Guo K; Feng Y; Guo Y
Cancer Med; 2020 Nov; 9(21):8029-8042. PubMed ID: 32931661
[TBL] [Abstract][Full Text] [Related]
26. Secondary hematopoietic malignancies in survivors of childhood cancer: an analysis of 111 cases from the Surveillance, Epidemiology, and End Result-9 registry.
Rihani R; Bazzeh F; Faqih N; Sultan I
Cancer; 2010 Sep; 116(18):4385-94. PubMed ID: 20549819
[TBL] [Abstract][Full Text] [Related]
27. Tumor location is an independent prognostic factor in head and neck Merkel cell carcinoma.
Smith VA; MaDan OP; Lentsch EJ
Otolaryngol Head Neck Surg; 2012 Mar; 146(3):403-8. PubMed ID: 22166964
[TBL] [Abstract][Full Text] [Related]
28. Late mortality, secondary malignancy and hospitalisation in teenage and young adult survivors of Hodgkin lymphoma: report of the Childhood/Adolescent/Young Adult Cancer Survivors Research Program and the BC Cancer Agency Centre for Lymphoid Cancer.
Bhuller KS; Zhang Y; Li D; Sehn LH; Goddard K; McBride ML; Rogers PC
Br J Haematol; 2016 Mar; 172(5):757-68. PubMed ID: 26727959
[TBL] [Abstract][Full Text] [Related]
29. Incidence of second metachronous head and neck cancers: population-based outcomes over 25 years.
Tiwana MS; Hay J; Wu J; Wong F; Cheung W; Olson RA
Laryngoscope; 2014 Oct; 124(10):2287-91. PubMed ID: 24729185
[TBL] [Abstract][Full Text] [Related]
30. Subsequent malignancies among long-term survivors of Hodgkin lymphoma and non-Hodgkin lymphoma: a pooled analysis of German cancer registry data (1990-2012).
Baras N; Dahm S; Haberland J; Janz M; Emrich K; Kraywinkel K; Salama A
Br J Haematol; 2017 Apr; 177(2):226-242. PubMed ID: 28106907
[TBL] [Abstract][Full Text] [Related]
31. Radiation-induced cancer after radiotherapy for non-Hodgkin's lymphoma of the head and neck: a retrospective study.
Toda K; Shibuya H; Hayashi K; Ayukawa F
Radiat Oncol; 2009 Jul; 4():21. PubMed ID: 19591686
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic radiation for lymphoma: risk of malignant mesothelioma.
Teta MJ; Lau E; Sceurman BK; Wagner ME
Cancer; 2007 Apr; 109(7):1432-8. PubMed ID: 17315168
[TBL] [Abstract][Full Text] [Related]
33. A Comparison of the NCDB and SEER Database for Research Involving Head and Neck Cancer.
Janz TA; Graboyes EM; Nguyen SA; Ellis MA; Neskey DM; Harruff EE; Lentsch EJ
Otolaryngol Head Neck Surg; 2019 Feb; 160(2):284-294. PubMed ID: 30129822
[TBL] [Abstract][Full Text] [Related]
34. Cannabinoid receptor-2 immunoreactivity is associated with survival in squamous cell carcinoma of the head and neck.
Klein Nulent TJ; Van Diest PJ; van der Groep P; Leusink FK; Kruitwagen CL; Koole R; Van Cann EM
Br J Oral Maxillofac Surg; 2013 Oct; 51(7):604-9. PubMed ID: 23601830
[TBL] [Abstract][Full Text] [Related]
35. Poor prognosis in patients with stage I and II oral tongue squamous cell carcinoma.
Rusthoven K; Ballonoff A; Raben D; Chen C
Cancer; 2008 Jan; 112(2):345-51. PubMed ID: 18041071
[TBL] [Abstract][Full Text] [Related]
36. Risk and outcome of non-Hodgkin lymphoma among classical Hodgkin lymphoma survivors.
Xavier AC; Armeson KE; Hill EG; Costa LJ
Cancer; 2013 Sep; 119(18):3385-92. PubMed ID: 23797978
[TBL] [Abstract][Full Text] [Related]
37. Small Cell and Squamous Cell Carcinomas of the Head and Neck: Comparing Incidence and Survival Trends Based on Surveillance, Epidemiology, and End Results (SEER) Data.
Bean MB; Liu Y; Jiang R; Steuer CE; Patel M; McDonald MW; Higgins KA; Beitler JJ; Shin DM; Saba NF
Oncologist; 2019 Dec; 24(12):1562-1569. PubMed ID: 31391295
[TBL] [Abstract][Full Text] [Related]
38. The impact of second primary malignancies on head and neck cancer survivors: a nationwide cohort study.
Liao LJ; Chou HW; Wang CT; Chung CS; Lai MS
PLoS One; 2013; 8(4):e62116. PubMed ID: 23614023
[TBL] [Abstract][Full Text] [Related]
39. Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma-Identification of high-risk populations to guide surveillance: A report from the Late Effects Study Group.
Holmqvist AS; Chen Y; Berano Teh J; Sun C; Birch JM; van den Bos C; Diller LR; Dilley K; Ginsberg J; Martin LT; Nagarajan R; Nathan PC; Neglia JP; Terenziani M; Tishler D; Meadows AT; Robison LL; Oberlin O; Bhatia S
Cancer; 2019 Apr; 125(8):1373-1383. PubMed ID: 30556153
[TBL] [Abstract][Full Text] [Related]
40. Trends in the Risks of Secondary Cancers in Patients With Hodgkin Lymphoma.
Kumar V; Garg M; Chandra AB; Mayorga VS; Ahmed S; Ailawadhi S
Clin Lymphoma Myeloma Leuk; 2018 Sep; 18(9):576-589.e1. PubMed ID: 29934060
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
